2015 Q3 Form 10-Q Financial Statement
#000107997315000532 Filed on August 11, 2015
Income Statement
Concept | 2015 Q3 | 2015 Q2 | 2014 Q4 |
---|---|---|---|
Revenue | $60.00K | $24.52K | $79.00K |
YoY Change | 66.67% | ||
Cost Of Revenue | $10.00K | $8.096K | $30.00K |
YoY Change | -19.3% | ||
Gross Profit | $40.00K | $16.42K | $51.00K |
YoY Change | 66.67% | ||
Gross Profit Margin | 66.67% | 66.98% | 64.56% |
Selling, General & Admin | $1.230M | $1.483M | $1.520M |
YoY Change | -16.51% | -11.47% | 7.8% |
% of Gross Profit | 3075.0% | 9028.73% | 2980.39% |
Research & Development | $430.0K | $552.4K | $900.0K |
YoY Change | -61.58% | -41.86% | -45.45% |
% of Gross Profit | 1075.0% | 3364.03% | 1764.71% |
Depreciation & Amortization | $36.00K | $38.00K | $70.00K |
YoY Change | -23.4% | -25.49% | -12.5% |
% of Gross Profit | 90.0% | 231.41% | 137.25% |
Operating Expenses | $1.640M | $2.035M | $2.390M |
YoY Change | -36.74% | -22.47% | -21.64% |
Operating Profit | -$1.600M | -$1.994M | -$2.339M |
YoY Change | -37.12% | -23.31% | -23.31% |
Interest Expense | $10.00K | $24.20K | -$20.00K |
YoY Change | -63.22% | -6.1% | -80.0% |
% of Operating Profit | |||
Other Income/Expense, Net | -$38.81K | $0.00 | |
YoY Change | -523.13% | -100.0% | |
Pretax Income | -$1.580M | -$2.030M | -$2.370M |
YoY Change | -37.55% | -21.62% | -24.28% |
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$1.580M | -$2.033M | -$2.370M |
YoY Change | -37.62% | -21.54% | -24.28% |
Net Earnings / Revenue | -2633.33% | -8293.16% | -3000.0% |
Basic Earnings Per Share | |||
Diluted Earnings Per Share | -$408.3K | -$524.5K | -$610.8K |
COMMON SHARES | |||
Basic Shares Outstanding | 30.99M shares | 30.99M shares | |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2015 Q3 | 2015 Q2 | 2014 Q4 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $18.90M | $20.40M | $24.50M |
YoY Change | -29.21% | -29.9% | 71.33% |
Cash & Equivalents | $3.200M | $4.868M | $3.540M |
Short-Term Investments | $15.70M | $15.60M | $21.00M |
Other Short-Term Assets | $500.0K | $200.0K | $400.0K |
YoY Change | 0.0% | -33.33% | -20.0% |
Inventory | |||
Prepaid Expenses | |||
Receivables | $58.00K | $24.00K | $17.00K |
Other Receivables | |||
Total Short-Term Assets | $19.40M | $20.59M | $24.90M |
YoY Change | -28.81% | -29.91% | 68.66% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $2.000M | $2.026M | $2.104M |
YoY Change | -6.18% | -6.47% | -7.19% |
Goodwill | $387.2K | $387.2K | $387.2K |
YoY Change | 0.0% | 0.0% | 0.0% |
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $1.714M | $1.724M | |
YoY Change | 2.38% | 6.95% | |
Total Long-Term Assets | $3.700M | $3.741M | $3.828M |
YoY Change | -2.6% | -2.61% | -1.32% |
TOTAL ASSETS | |||
Total Short-Term Assets | $19.40M | $20.59M | $24.90M |
Total Long-Term Assets | $3.700M | $3.741M | $3.828M |
Total Assets | $23.10M | $24.33M | $28.72M |
YoY Change | -25.61% | -26.75% | 54.1% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $200.0K | $293.7K | $437.5K |
YoY Change | -61.65% | -41.25% | -43.94% |
Accrued Expenses | $400.0K | $342.6K | $325.4K |
YoY Change | -13.67% | -37.01% | -64.15% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $160.4K |
YoY Change | -7.54% | ||
Long-Term Debt Due | $400.0K | $200.0K | $300.0K |
YoY Change | 0.0% | 0.0% | 0.0% |
Total Short-Term Liabilities | $1.100M | $950.4K | $1.782M |
YoY Change | -38.5% | -39.33% | -20.77% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $1.900M | $1.900M | $2.000M |
YoY Change | -5.0% | -9.52% | -9.09% |
Other Long-Term Liabilities | $1.200M | $1.200M | $1.300M |
YoY Change | -7.69% | -7.69% | 0.0% |
Total Long-Term Liabilities | $3.100M | $3.100M | $3.300M |
YoY Change | -6.06% | -8.82% | -5.71% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $1.100M | $950.4K | $1.782M |
Total Long-Term Liabilities | $3.100M | $3.100M | $3.300M |
Total Liabilities | $4.200M | $4.080M | $5.039M |
YoY Change | -17.77% | -17.54% | -11.45% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$101.0M | -$96.82M | |
YoY Change | 9.93% | 12.09% | |
Common Stock | |||
YoY Change | |||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $18.90M | $20.25M | $23.69M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $23.10M | $24.30M | $28.72M |
YoY Change | -25.61% | -26.83% | 54.1% |
Cashflow Statement
Concept | 2015 Q3 | 2015 Q2 | 2014 Q4 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$1.580M | -$2.033M | -$2.370M |
YoY Change | -37.62% | -21.54% | -24.28% |
Depreciation, Depletion And Amortization | $36.00K | $38.00K | $70.00K |
YoY Change | -23.4% | -25.49% | -12.5% |
Cash From Operating Activities | -$1.390M | -$1.540M | -$1.950M |
YoY Change | -39.3% | -27.36% | -30.36% |
INVESTING ACTIVITIES | |||
Capital Expenditures | -$10.00K | -$40.00K | -$100.0K |
YoY Change | -50.0% | -42.86% | 100.0% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | -$140.0K | $2.340M | $1.350M |
YoY Change | -104.61% | -114.2% | -68.53% |
Cash From Investing Activities | -$150.0K | $2.310M | $1.250M |
YoY Change | -104.98% | -113.97% | -70.52% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | -90.00K | -110.0K | -140.0K |
YoY Change | -10.0% | -100.6% | 0.0% |
NET CHANGE | |||
Cash From Operating Activities | -1.390M | -1.540M | -1.950M |
Cash From Investing Activities | -150.0K | 2.310M | 1.250M |
Cash From Financing Activities | -90.00K | -110.0K | -140.0K |
Net Change In Cash | -1.630M | 660.0K | -840.0K |
YoY Change | -362.9% | -400.0% | -164.62% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$1.390M | -$1.540M | -$1.950M |
Capital Expenditures | -$10.00K | -$40.00K | -$100.0K |
Free Cash Flow | -$1.380M | -$1.500M | -$1.850M |
YoY Change | -39.21% | -26.83% | -32.73% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
3569161 | USD | |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1260150 | USD | |
CY2014Q4 | us-gaap |
Short Term Investments
ShortTermInvestments
|
20998789 | USD |
CY2014Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
357083 | USD |
CY2015Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
30990029 | shares |
CY2015Q2 | us-gaap |
Assets Current
AssetsCurrent
|
20586054 | USD |
CY2015Q2 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
155325 | USD |
us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.21 | ||
us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
30990029 | shares | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
780983 | USD | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
729413 | USD | |
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
129794 | USD | |
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
153592 | USD | |
us-gaap |
Recognition Of Deferred Revenue
RecognitionOfDeferredRevenue
|
48349 | USD | |
us-gaap |
Recognition Of Deferred Revenue
RecognitionOfDeferredRevenue
|
47349 | USD | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
30260 | USD | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
18943 | USD | |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-232018 | USD | |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-209658 | USD | |
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-143793 | USD | |
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-280565 | USD | |
us-gaap |
Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
|
-547607 | USD | |
us-gaap |
Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
|
127000 | USD | |
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
17161 | USD | |
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-363859 | USD | |
us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
USD | ||
us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
68584 | USD | |
us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-3825014 | USD | |
us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-4961637 | USD | |
us-gaap |
Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
|
16216718 | USD | |
us-gaap |
Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
|
28420458 | USD | |
us-gaap |
Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
|
21652610 | USD | |
us-gaap |
Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
|
11714964 | USD | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
USD | ||
CY2015Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
2026365 | USD |
CY2014Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
2103880 | USD |
CY2014Q4 | us-gaap |
Assets Current
AssetsCurrent
|
24895783 | USD |
CY2015Q2 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
1714286 | USD |
CY2014Q4 | us-gaap |
Common Stock No Par Value
CommonStockNoParValue
|
||
CY2015Q2 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
1482608 | USD |
CY2015Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
552408 | USD |
CY2015Q2 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
61810 | USD |
CY2014Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
1724190 | USD |
CY2015Q2 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
24517 | USD |
CY2015Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-101044482 | USD |
CY2015Q2 | us-gaap |
Licenses Revenue
LicensesRevenue
|
24174 | USD |
CY2015Q2 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
293726 | USD |
CY2014Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
3539911 | USD |
CY2014Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
437519 | USD |
CY2014Q4 | us-gaap |
Liabilities
Liabilities
|
5038730 | USD |
CY2015Q2 | us-gaap |
Assets
Assets
|
24326705 | USD |
CY2014Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
30990029 | shares |
CY2014Q4 | us-gaap |
Assets
Assets
|
28723853 | USD |
CY2015Q2 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
8096 | USD |
CY2015Q2 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2015Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
30990029 | shares |
CY2014Q2 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
USD | |
CY2015Q2 | us-gaap |
Liabilities
Liabilities
|
4080207 | USD |
CY2014Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
609417 | USD |
CY2014Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
60000000 | shares |
CY2015Q2 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
342561 | USD |
CY2014Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
325400 | USD |
CY2015Q2 | us-gaap |
Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
|
121290980 | USD |
CY2015Q2 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
155628 | USD |
CY2014Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
312934 | USD |
CY2015Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
20246498 | USD |
CY2015Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
4867832 | USD |
CY2015Q2 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
96698 | USD |
CY2014Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
96698 | USD |
CY2014Q2 | us-gaap |
Licenses Revenue
LicensesRevenue
|
24174 | USD |
CY2015Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
950423 | USD |
CY2015Q2 | us-gaap |
Short Term Investments
ShortTermInvestments
|
15562897 | USD |
CY2015Q2 | us-gaap |
Common Stock No Par Value
CommonStockNoParValue
|
||
CY2014Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2014Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1781968 | USD |
CY2014Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
30990029 | shares |
CY2015Q2 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
1919420 | USD |
CY2015Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
60000000 | shares |
CY2014Q2 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
USD | |
CY2014Q4 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
1998049 | USD |
CY2015Q2 | us-gaap |
Gross Profit
GrossProfit
|
16421 | USD |
CY2014Q2 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
1674719 | USD |
CY2015Q2 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
1210364 | USD |
CY2014Q4 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
1258713 | USD |
CY2014Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
950147 | USD |
CY2014Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
2624866 | USD |
CY2015Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1994421 | USD |
CY2014Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2600692 | USD |
CY2015Q2 | us-gaap |
Interest Expense
InterestExpense
|
24195 | USD |
CY2014Q2 | us-gaap |
Interest Expense
InterestExpense
|
25768 | USD |
CY2015Q2 | us-gaap |
Investment Income Net
InvestmentIncomeNet
|
-14619 | USD |
us-gaap |
Licenses Revenue
LicensesRevenue
|
47349 | USD | |
us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
3018459 | USD | |
CY2015Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
2035016 | USD |
CY2014Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2591519 | USD |
CY2015Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.07 | |
CY2014Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.08 | |
CY2015Q2 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
30990029 | shares |
CY2014Q2 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
30782937 | shares |
us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
35805 | USD | |
us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
51728 | USD | |
us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
12103 | USD | |
us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
31907 | USD | |
us-gaap |
Gross Profit
GrossProfit
|
23702 | USD | |
us-gaap |
Gross Profit
GrossProfit
|
19821 | USD | |
us-gaap |
Licenses Revenue
LicensesRevenue
|
48349 | USD | |
CY2014Q2 | us-gaap |
Investment Income Net
InvestmentIncomeNet
|
34941 | USD |
CY2015Q2 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-38814 | USD |
CY2014Q2 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
9173 | USD |
CY2015Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2033235 | USD |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
2002445 | USD | |
us-gaap |
Operating Expenses
OperatingExpenses
|
4278609 | USD | |
us-gaap |
Operating Expenses
OperatingExpenses
|
5571606 | USD | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-4206558 | USD | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-5504436 | USD | |
us-gaap |
Interest Expense
InterestExpense
|
49259 | USD | |
us-gaap |
Interest Expense
InterestExpense
|
62558 | USD | |
us-gaap |
Investment Income Net
InvestmentIncomeNet
|
36209 | USD | |
us-gaap |
Investment Income Net
InvestmentIncomeNet
|
27826 | USD | |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-13050 | USD | |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-34732 | USD | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-4219608 | USD | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-5539168 | USD | |
us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.14 | ||
us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
26236252 | shares | |
CY2015Q2 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
24000 | USD |
CY2015Q2 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
1600 | USD |
CY2015Q2 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
6200000 | shares |
CY2014Q2 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
5300000 | shares |
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
5300000 | shares | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
2200 | USD | |
us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
47022 | USD | |
us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
113304 | USD | |
us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
5388870 | USD | |
us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-16820998 | USD | |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
USD | ||
us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
235935 | USD | |
us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
245933 | USD | |
us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
-235935 | USD | |
us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
19876719 | USD | |
us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
1327921 | USD | |
us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-1905916 | USD | |
CY2013Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
5658683 | USD |
CY2014Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
3752767 | USD |
us-gaap |
Interest Paid
InterestPaid
|
49740 | USD | |
us-gaap |
Interest Paid
InterestPaid
|
52928 | USD | |
us-gaap |
Other Noncash Expense
OtherNoncashExpense
|
4647 | USD | |
us-gaap |
Other Noncash Expense
OtherNoncashExpense
|
USD | ||
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
20122652 | USD | |
CY2015Q2 | us-gaap |
Investments And Cash
InvestmentsAndCash
|
20431000 | USD |
CY2015Q2 | appy |
Working Capital
WorkingCapital
|
19636000 | USD |
CY2015Q2 | appy |
Percentage Of Investment Portfolio Cash And Cash Equivalent
PercentageOfInvestmentPortfolioCashAndCashEquivalent
|
0.20 | pure |
us-gaap |
Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
|
12000 | USD | |
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
6200000 | shares | |
CY2015Q2 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
5391044 | USD |
CY2014Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
5391044 | USD |
CY2015Q2 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
3364679 | USD |
CY2014Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
3287164 | USD |
CY2014Q4 | us-gaap |
Goodwill
Goodwill
|
387239 | USD |
us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
5000 | USD | |
CY2015Q2 | us-gaap |
Other Short Term Borrowings
OtherShortTermBorrowings
|
USD | |
CY2014Q4 | us-gaap |
Other Short Term Borrowings
OtherShortTermBorrowings
|
160375 | USD |
CY2015Q2 | us-gaap |
Notes Payable
NotesPayable
|
2075048 | USD |
CY2015Q2 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
|
82000 | USD |
CY2014Q4 | us-gaap |
Notes Payable
NotesPayable
|
2310983 | USD |
us-gaap |
Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
|
16000 | USD | |
CY2015Q2 | us-gaap |
Depreciation
Depreciation
|
38000 | USD |
us-gaap |
Depreciation
Depreciation
|
78000 | USD | |
CY2014Q2 | us-gaap |
Depreciation
Depreciation
|
51000 | USD |
us-gaap |
Depreciation
Depreciation
|
103000 | USD | |
CY2015Q2 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
559922 | USD |
CY2014Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
507644 | USD |
CY2015Q2 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
1327047 | USD |
CY2014Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
1336951 | USD |
CY2015Q2 | us-gaap |
Goodwill
Goodwill
|
387239 | USD |
CY2015Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
97000 | USD |
CY2015Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
97000 | USD |
us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
USD | ||
CY2015Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
97000 | USD |
CY2015Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
|
97000 | USD |
CY2015Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
97000 | USD |
CY2015Q2 | us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
5000 | USD |
CY2014Q2 | us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
USD | |
CY2015Q2 | us-gaap |
Secured Debt
SecuredDebt
|
2075048 | USD |
CY2014Q4 | us-gaap |
Secured Debt
SecuredDebt
|
2150608 | USD |
CY2015Q2 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
|
1268000 | USD |
CY2014Q2 | us-gaap |
Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
|
1543000 | USD |
CY2014Q2 | appy |
Placement Fee Percentage
PlacementFeePercentage
|
0.065 | pure |
us-gaap |
Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
|
1161570 | shares | |
CY2014Q2 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
1.36 | |
us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
1580000 | USD | |
CY2014Q2 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
39079 | shares |
CY2014Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
14000 | USD |
CY2014Q2 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
8335000 | shares |
CY2014Q2 | us-gaap |
Shares Issued Price Per Share
SharesIssuedPricePerShare
|
2.40 | |
CY2014Q2 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
20000000 | USD |
CY2015Q2 | us-gaap |
Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
|
77000 | USD |
CY2015Q2 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
|
159000 | USD |
CY2015Q2 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
|
166000 | USD |
CY2015Q2 | appy |
Long Term Debt Maturities Repayments Of Principal After Year Six
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearSix
|
238000 | USD |
CY2015Q2 | appy |
Long Term Debt Maturities Repayments Of Principal In Year Six
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSix
|
85000 | USD |
CY2014Q2 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
2.09 | |
CY2014Q2 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
82000 | USD |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
|
1912205 | shares |
CY2014Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
|
3673126 | shares |
CY2015Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
347581 | USD |
CY2014Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
326392 | USD |
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
780983 | USD | |
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
729413 | USD | |
us-gaap |
Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
|
0 | shares | |
appy |
Prior Written Notice Period For Termination Of License Agreement By Licensee
PriorWrittenNoticePeriodForTerminationOfLicenseAgreementByLicensee
|
P180D | ||
CY2015Q2 | appy |
License Agreement Maximum Milestone Payments
LicenseAgreementMaximumMilestonePayments
|
1100000 | USD |
CY2015Q2 | appy |
Additional Milestone Maximum Payments
AdditionalMilestoneMaximumPayments
|
2000000 | USD |
CY2015Q2 | us-gaap |
Other Commitment Due In Next Twelve Months
OtherCommitmentDueInNextTwelveMonths
|
20000 | USD |
CY2015Q2 | appy |
License And Milestone Payments Revenue
LicenseAndMilestonePaymentsRevenue
|
1920000 | USD |
CY2015Q2 | us-gaap |
Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
|
363700 | USD |
CY2015Q2 | appy |
Deferred Revenue Gross
DeferredRevenueGross
|
1556300 | USD |
CY2015Q2 | appy |
Deferred Revenue Accumulated Recognition
DeferredRevenueAccumulatedRecognition
|
249238 | USD |
CY2015Q2 | us-gaap |
Deferred Revenue
DeferredRevenue
|
1307062 | USD |
us-gaap |
Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
|
P197M | ||
CY2015Q2 | us-gaap |
Contractual Obligation
ContractualObligation
|
10000 | USD |
CY2014Q4 | us-gaap |
Contractual Obligation
ContractualObligation
|
10000 | USD |
dei |
Entity Registrant Name
EntityRegistrantName
|
Venaxis, Inc. | ||
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001167419 | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2015-06-30 | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Smaller Reporting Company | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2015 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q2 |